Cargando…

Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models

Recent research highlights the key role of iron dyshomeostasis in the pathogenesis of prostate cancer (PCa). PCa cells are heavily dependent on bioavailable iron, which frequently results in the reprogramming of iron uptake and storage pathways. Although advanced-stage PCa is currently incurable, bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Currie, Crawford, Bjerknes, Christian, Myklebust, Tor Åge, Framroze, Bomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607736/
https://www.ncbi.nlm.nih.gov/pubmed/37894914
http://dx.doi.org/10.3390/ijms242015231
_version_ 1785127612357541888
author Currie, Crawford
Bjerknes, Christian
Myklebust, Tor Åge
Framroze, Bomi
author_facet Currie, Crawford
Bjerknes, Christian
Myklebust, Tor Åge
Framroze, Bomi
author_sort Currie, Crawford
collection PubMed
description Recent research highlights the key role of iron dyshomeostasis in the pathogenesis of prostate cancer (PCa). PCa cells are heavily dependent on bioavailable iron, which frequently results in the reprogramming of iron uptake and storage pathways. Although advanced-stage PCa is currently incurable, bioactive peptides capable of modulating key iron-regulatory genes may constitute a means of exploiting a metabolic adaptation necessary for tumor growth. Recent annual increases in PCa incidence have been reported, highlighting the urgent need for novel treatments. We examined the ability of LNCaP, PC3, VCaP, and VCaP-EnzR cells to form colonies in the presence of androgen receptor inhibitors (ARI) and a series of iron-gene modulating oligopeptides (FT-001-FT-008). The viability of colonies following treatment was determined with clonogenic assays, and the expression levels of FTH1 (ferritin heavy chain 1) and TFRC (transferrin receptor) were determined with quantitative polymerase chain reaction (PCR). Peptides and ARIs combined significantly reduced PCa cell growth across all phenotypes, of which two peptides were the most effective. Colony growth suppression generally correlated with the magnitude of concurrent increases in FTH1 and decreases in TFRC expression for all cells. The results of this study provide preliminary insight into a novel approach at targeting iron dysmetabolism and sensitizing PCa cells to established cancer treatments.
format Online
Article
Text
id pubmed-10607736
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106077362023-10-28 Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models Currie, Crawford Bjerknes, Christian Myklebust, Tor Åge Framroze, Bomi Int J Mol Sci Article Recent research highlights the key role of iron dyshomeostasis in the pathogenesis of prostate cancer (PCa). PCa cells are heavily dependent on bioavailable iron, which frequently results in the reprogramming of iron uptake and storage pathways. Although advanced-stage PCa is currently incurable, bioactive peptides capable of modulating key iron-regulatory genes may constitute a means of exploiting a metabolic adaptation necessary for tumor growth. Recent annual increases in PCa incidence have been reported, highlighting the urgent need for novel treatments. We examined the ability of LNCaP, PC3, VCaP, and VCaP-EnzR cells to form colonies in the presence of androgen receptor inhibitors (ARI) and a series of iron-gene modulating oligopeptides (FT-001-FT-008). The viability of colonies following treatment was determined with clonogenic assays, and the expression levels of FTH1 (ferritin heavy chain 1) and TFRC (transferrin receptor) were determined with quantitative polymerase chain reaction (PCR). Peptides and ARIs combined significantly reduced PCa cell growth across all phenotypes, of which two peptides were the most effective. Colony growth suppression generally correlated with the magnitude of concurrent increases in FTH1 and decreases in TFRC expression for all cells. The results of this study provide preliminary insight into a novel approach at targeting iron dysmetabolism and sensitizing PCa cells to established cancer treatments. MDPI 2023-10-16 /pmc/articles/PMC10607736/ /pubmed/37894914 http://dx.doi.org/10.3390/ijms242015231 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Currie, Crawford
Bjerknes, Christian
Myklebust, Tor Åge
Framroze, Bomi
Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models
title Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models
title_full Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models
title_fullStr Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models
title_full_unstemmed Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models
title_short Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models
title_sort assessing the potential of small peptides for altering expression levels of the iron-regulatory genes fth1 and tfrc and enhancing androgen receptor inhibitor activity in in vitro prostate cancer models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607736/
https://www.ncbi.nlm.nih.gov/pubmed/37894914
http://dx.doi.org/10.3390/ijms242015231
work_keys_str_mv AT curriecrawford assessingthepotentialofsmallpeptidesforalteringexpressionlevelsoftheironregulatorygenesfth1andtfrcandenhancingandrogenreceptorinhibitoractivityininvitroprostatecancermodels
AT bjerkneschristian assessingthepotentialofsmallpeptidesforalteringexpressionlevelsoftheironregulatorygenesfth1andtfrcandenhancingandrogenreceptorinhibitoractivityininvitroprostatecancermodels
AT myklebusttorage assessingthepotentialofsmallpeptidesforalteringexpressionlevelsoftheironregulatorygenesfth1andtfrcandenhancingandrogenreceptorinhibitoractivityininvitroprostatecancermodels
AT framrozebomi assessingthepotentialofsmallpeptidesforalteringexpressionlevelsoftheironregulatorygenesfth1andtfrcandenhancingandrogenreceptorinhibitoractivityininvitroprostatecancermodels